News

The King’s College London Gene Therapy Vector Facility (GTVF) is pleased to support the upcoming KHP Advanced Therapies Conference 2026, taking place on Monday 18 May 2026 in London.

Hosted by King's Health Partners, this full-day event will bring together clinicians, researchers and patients to explore the future of advanced therapies across a range of indications including cystic fibrosis, liver disease, retinal disorders and more.

Our own Centre Director Professor Robin Ali will be speaking alongside an exciting keynote from Professor Marcela Maus and many other inspiring leaders showcasing innovation across the KHP ecosystem and beyond.

At GTVF, we are committed to supporting the translation of advanced therapies from discovery through to clinical application. We specialise in GMP viral vector manufacturing as either drug substance or drug product and are here to support the exciting research community at KCL/KCH/KHP and beyond.

A big thank you to Dr Reuben Benjamin and the KHP Haematology team for organising this exciting event. We encourage colleagues and collaborators across the field to attend and connect with the vibrant advanced therapies community in London.

👉 Learn more and register here: https://www.eventbrite.co.uk/e/khp-advanced-therapies-conference-tickets-1984874042693?aff=oddtdtcreator